Associations Between Neuropathy, Nephropathy and Hearing Loss in Individuals with Type 2 Diabetes
Open Access
- 20 May 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (5) , 1153
Abstract
Aims: The aim of this study was to investigate the associations between symptomatic hearing loss (HL), neuropathy, and nephropathy in subjects with Type 2 diabetes mellitus (T2DM). Furthermore, the study evaluated whether HL was associated with chronic low-grade inflammation, assessed based on plasma levels of tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hsCRP), and explored potential sex-specific differences. Materials and Methods: We included 4245 subjects with T2DM from The Danish Centre for Strategic Research in Type 2 Diabetes cohort. Symptomatic HL was defined using ICD-10 codes. In 2016, a questionnaire was sent out to evaluate neuropathy using the Michigan Neuropathy Screening Instrument (MNSI ≥ 4). Nephropathy was defined as urinary albumin-to-creatinine ratio (UACR) >30 mg/g. Plasma levels of TNF-α, IL-6, and hsCRP were measured at enrolment from 2010 to 2016. Multivariable logistic regression was used, adjusting for covariates. Results: Neuropathy was significantly associated with HL (OR = 1.83, 95%CI [1.42, 2.35], p < 0.001), and the association was stronger in women (OR = 2.74 [1.81, 4.14], p < 0.001) compared to men (OR = 1.44 [1.04, 1.99], p < 0.05) (P-interaction = 0.020). No significant association was found between nephropathy and HL. Among inflammatory markers, only the highest tertile of TNF-α levels was significantly associated with HL compared to the lowest tertile (OR = 1.40 [1.07, 1.82], p < 0.05) without any sex interaction. Conclusions: In subjects with T2DM, neuropathy was associated with symptomatic HL, and the association seemed to be stronger in females. Among chronic low-grade inflammation markers, only TNF-α was significantly associated with symptomatic HL. Additionally, no significant association was found between nephropathy and HL.Keywords
Funding Information
- Danish Agency for Science (09-067009)
- Danish Agency for Science (09-075724)
- Sundhedsstyrelsen (NNF17SA0030962-2)
- Diabetesforeningen (NNF20O0063292)
- Region Syddanmark (NNF17SA0030364)
- Novo Nordisk Fonden (NNF18CC0034900)
- Novo Nordisk Fonden (NNF23SA0084103)
This publication has 39 references indexed in Scilit:
- Association of Polygenic Risk Scores for Hearing Difficulty in Older Adults With Hearing Loss in Mid-Childhood and MidlifeJAMA Otolaryngology–Head & Neck Surgery, 2023
- Association of different severity of diabetic retinopathy and hearing loss in type 2 diabetes mellitusAmerican Journal of Otolaryngology, 2022
- Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitusQuality of Life Research, 2020
- Age‐related hearing loss: Why we need to think about sex as a biological variableJournal of Neuroscience Research, 2020
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Is hearing impairment in diabetic patients correlated to other complications?Journal of Diabetes & Metabolic Disorders, 2018
- Hearing impairment in type 2 diabetics and patients with early diabetic nephropathyJournal of Diabetes and its Complications, 2018
- Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapyAgeing Research Reviews, 2017
- Hearing Loss in Type 2 Diabetes in Association with Diabetic NeuropathyArchives of Medical Research, 2017
- Clinical Study to Evaluate the Association Between Sensorineural Hearing Loss and Diabetes Mellitus in Poorly Controlled Patients Whose HbA1c >8Indian Journal of Otolaryngology and Head & Neck Surgery, 2016